Category
Price Transparency Reporting Just Got Riskier — Here’s What You Can Do
Price Transparency reporting is high stakes for pharmaceutical manufacturers, and the consequences of not keeping pace are growing steeper by the day. Civil monetary penalties are real, are rising, and are being enforced with surprising speed and severity. In fact, one manufacturer was recently hit with… Read More
Launching a New Pharmaceutical Product: Why a Checklist is Essential
Rolling out a new pharmaceutical product is an exciting milestone, but it comes with significant regulatory and operational challenges. For manufacturers required to meet reporting obligations under CMS, Price Transparency laws, and other government pricing programs, having a structured approach is critical to ensure compliance and avoid costly pitfalls. This… Read More
Leveraging AI in Compliance: Join Our Session at PCC 2025
As we continue to navigate the evolving landscape of compliance in the pharmaceutical industry, the role of artificial intelligence (AI) is becoming increasingly pivotal. At the upcoming Pharmaceutical Compliance Congress (PCC) 2025, RLDatix Life Sciences is proud to be part of a dynamic panel discussion titled “How to Leverage… Read More
Coaching in 2025: Hard-Won Lessons from the Trenches
Coaching has always been an essential part of great leadership, but —for most sales managers — the way we coach today looks nothing like it did just a few years ago. Back in 2017, we wrote a coach-the-coaches guide for sales managers called War Stories… Read More
Medicare Inflation Rebates in 2025: What Pharma Manufacturers Need to Know
Are you ready for the biggest shift in pharmaceutical pricing regulations in years? Medicare inflation rebates will take full effect in 2025, bringing new financial and compliance challenges for pharmaceutical manufacturers. As part of the Inflation Reduction Act (IRA) of 2022, these rebates require drug… Read More
Transforming Healthcare Pricing: Implications of Trump’s Executive Order on Transparency
On February 25, 2025, President Donald J. Trump issued an Executive Order aimed at transforming healthcare pricing transparency. This directive requires the Departments of the Treasury, Labor, and Health and Human Services to implement regulations mandating that hospitals and insurers disclose actual, real-time pricing data, including the costs of… Read More
Simplifying Compliance with the Porzio Compliance Digest
Navigating the complex world of compliance in the life sciences industry can feel overwhelming. Regulations around distribution, transparency, and promotional practices are constantly evolving, making it critical for organizations to stay informed and proactive. That’s where RLDatix Life Sciences’ Porzio Compliance Digest comes in. It’s a powerful compliance… Read More
5 Key Steps to Follow Before You Calculate Government Pricing
Accurate government pricing calculations are a cornerstone of operational excellence in Life Sciences. Missteps can be serious, leading to financial penalties, compliance risks, and reputational damage. As Sarah McClure, Vice President of Knowledge Management at RLDatix Life Sciences, highlighted in our recent webinar on … Read More
Mapping the Revenue Management Lifecycle for Life Sciences
Revenue management is the cornerstone of financial success for emerging life sciences companies. It ensures financial health while balancing growth strategies with compliance and operational efficiency. With a dynamic and competitive landscape, mastering this process is more critical than ever. This guide maps out the three… Read More